Lloyd Brian G. 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 6, 2025

Form 4

Period: 2025-03-04

CHIEF LEGAL OFFICER, SECRETARY

Transactions

Gift
Common Stock, No Par Value
2025-03-04−48→ 38,945 total
Exercise/Conversion
Common Stock, No Par Value
2025-03-05$55.73/sh+30,000$1,671,900→ 68,945 total
Sale
Common Stock, No Par Value
2025-03-05$102.90/sh−30,000$3,087,000→ 38,945 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2025-03-05−30,000→ 0 total
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (30,000 underlying)

Holdings

Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (16,722 underlying)
16,722
Non-qualified stock options (right to buy)
Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (8,094 underlying)
8,094
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying)
13,576
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying)
9,681

Footnotes (6)

[F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.92 to $103.36, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F2]Become exercisable in equal annual installments of 20% commencing on 03/01/2020.
[F3]Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
[F4]Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
[F5]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
[F6]Become exercisable in equal annual installments of 25% commencing on 02/28/2024.

Documents

1 file